(CRNX) Crinetics - Performance -41.2% in 12m
CRNX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
37.04%
#10 in Peer-Group
Rel. Strength
13.13%
#6676 in Stock-Universe
Total Return 12m
-41.21%
#109 in Peer-Group
Total Return 5y
119.52%
#8 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 60.69 USD |
| 52 Week Low | 25.56 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 70.83 |
| Buy/Sell Signal +-5 | -1.53 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CRNX (-41.2%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-2.07% | 25.1% | -6.95% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.57% | 27.9% | 14.5% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: CRNX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRNX
| Total Return (including Dividends) | CRNX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 2.02% | 3.06% | 3.54% |
| 3 Months | 7.32% | 12.25% | 16.07% |
| 12 Months | -41.21% | -13.98% | 12.18% |
| 5 Years | 119.52% | -27.36% | 107.69% |
| Trend Score (consistency of price movement) | CRNX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 16.1% | 76.5% | 91.9% |
| 3 Months | -23.8% | 79.3% | 97.5% |
| 12 Months | -80.7% | -87.3% | 47% |
| 5 Years | 80.6% | -51.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th48.50 | -1.01% | -1.46% |
| 3 Month | %th39.50 | -4.40% | -7.54% |
| 12 Month | %th46.00 | -31.66% | -47.59% |
| 5 Years | %th96.50 | 202.19% | 5.70% |
FAQs
Does Crinetics (CRNX) outperform the market?
No,
over the last 12 months CRNX made -41.21%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.98%.
Over the last 3 months CRNX made 7.32%, while XBI made 12.25%.
Performance Comparison CRNX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CRNX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.1% | -1.5% | -18.9% | -53% |
| US NASDAQ 100 | QQQ | 7.6% | -2.3% | -21.4% | -54% |
| German DAX 40 | DAX | 9% | 0.5% | -29.7% | -70% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.5% | -2.9% | -22.9% | -61% |
| Hongkong Hang Seng | HSI | 7.5% | -0.4% | -40.9% | -76% |
| India NIFTY 50 | INDA | 9.8% | 1.4% | -20.4% | -38% |
| Brasil Bovespa | EWZ | 12.7% | 5% | -31% | -42% |
CRNX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.1% | 0.2% | -23.1% | -65% |
| Consumer Discretionary | XLY | 7.7% | -0.6% | -10.2% | -57% |
| Consumer Staples | XLP | 10% | 2.8% | -19.7% | -48% |
| Energy | XLE | 10.2% | 2.3% | -8.7% | -39% |
| Financial | XLF | 9.5% | -0.6% | -18.5% | -63% |
| Health Care | XLV | 10.1% | 3.9% | -8.5% | -32% |
| Industrial | XLI | 7.7% | -2.7% | -24.8% | -63% |
| Materials | XLB | 10.7% | 0.4% | -16.8% | -42% |
| Real Estate | XLRE | 8.7% | 2.6% | -17.7% | -48% |
| Technology | XLK | 7.8% | -4.3% | -24.8% | -52% |
| Utilities | XLU | 7.3% | 0.1% | -21.6% | -63% |
| Aerospace & Defense | XAR | 5.3% | -7.2% | -39.5% | -90% |
| Biotech | XBI | 7% | -1% | -10.4% | -27% |
| Homebuilder | XHB | 9.8% | -3.5% | -5.6% | -34% |
| Retail | XRT | 9.3% | -0.9% | -14.8% | -46% |
CRNX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.6% | 6.26% | -2.57% | -35% |
| Natural Gas | UNG | 3.6% | 10.5% | 5.4% | -49% |
| Gold | GLD | 7.5% | 3.6% | -36.6% | -78% |
| Silver | SLV | 5.5% | -1.7% | -35.9% | -63% |
| Copper | CPER | 6.8% | -11.6% | -37.7% | -64% |
CRNX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.6% | 2.2% | -13.4% | -37% |
| iShares High Yield Corp. Bond | HYG | 8.6% | 1.1% | -17% | -50% |